Intercept Drug Gets Black-Box Warning After Dosing Deaths
The U.S. Food and Drug Administration said Thursday it is adding a black-box warning to Intercept Pharmaceuticals Inc.'s liver disease treatment Ocaliva in an effort to prevent incorrect daily dosing instead...To view the full article, register now.
Already a subscriber? Click here to view full article